Laurel Habel to Gene Expression Profiling
This is a "connection" page, showing publications Laurel Habel has written about Gene Expression Profiling.
Connection Strength
0.503
-
A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients. Breast Cancer Res. 2006; 8(3):R25.
Score: 0.241
-
Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression. Breast Cancer Res Treat. 2014 Apr; 144(3):689-99.
Score: 0.103
-
Is age just a number? Oncotype DX testing and chemotherapy use in the post-TAILORx era. Cancer. 2025 Dec 15; 131(24):e70218.
Score: 0.058
-
MiXcan: a framework for cell-type-aware transcriptome-wide association studies with an application to breast cancer. Nat Commun. 2023 Jan 23; 14(1):377.
Score: 0.048
-
Breast cancer multigene testing trends and impact on chemotherapy use. Am J Manag Care. 2016 05 01; 22(5):e153-60.
Score: 0.030
-
A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies. Lancet. 2012 Mar 03; 379(9818):823-32.
Score: 0.022